Takeharu Yamanaka

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study.

T. Yamanaka, K. Goto, Kazuhito Suzuki, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival update in randomized phase II trial of S-1/cisplatin (SP) or docetaxel/cisplatin (DP) with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC)-TORG1018.

Y. Hosomi, Y. Takiguchi, N. Nogami, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.